Literature DB >> 2328196

The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.

P A Winstanley1, J W Coleman, J L Maggs, A M Breckenridge, B K Park.   

Abstract

The cytotoxicity of amodiaquine (AQ), amodiaquine quinoneimine (AQQI) and desethylamodiaquine (AQm) has been assessed in comparison with that of chloroquine (CQ) using mononuclear leucocytes (MNL) and granulocyte/monocyte colony forming units (GM-CFU) from haematologically normal subjects. Toxicity toward MNL was assessed after 2 h and 16 h incubations with each compound. After 2 h, AQ, AQm and AQQI but not CQ (within the concentration range 1-100 mumols l-1) produced a significant decrease in cell viability. After 16 h, all four compounds significantly increased cell death. After both 2 h and 16 h incubations CQ was the least toxic and AQQI the most toxic of the four compounds towards MNL. Toxicity to GM-CFU was assessed by the inhibition of colony formation in vitro. After 10-14 days incubation, there was significant concentration-dependent inhibition of colony formation by AQ, AQm, AQQI and CQ (within the range 0.1-10.0 mumols l-1). There were no significant differences between the ability of the four compounds to inhibit colony formation but toxicity towards GM-CFU was observed at drug concentrations at least 10-fold lower than those that were toxic to MNL. These data show that the four compounds are equally toxic in vitro toward GM-CFU, although some differences in their toxicity toward MNL were seen. The possible mechanisms of AQ's toxicity are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2328196      PMCID: PMC1380119          DOI: 10.1111/j.1365-2125.1990.tb03667.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.

Authors:  E G Rhodes; J Ball; I M Franklin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

2.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

3.  A cell line secreting stimulating factors for CFU-GEMM culture.

Authors:  C D Myers; F E Katz; G Joshi; J L Millar
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

4.  Drug-protein conjugates--XVIII. Detection of antibodies towards the antimalarial amodiaquine and its quinone imine metabolite in man and the rat.

Authors:  G Christie; A M Breckenridge; B K Park
Journal:  Biochem Pharmacol       Date:  1989-05-01       Impact factor: 5.858

5.  Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.

Authors:  C S Hatton; T E Peto; C Bunch; G Pasvol; S J Russell; C R Singer; G Edwards; P Winstanley
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

6.  Cytotoxic effects of N-acetyl-p-benzoquinone imine, a common arylating intermediate of paracetamol and N-hydroxyparacetamol.

Authors:  J A Holme; D C Dahlin; S D Nelson; E Dybing
Journal:  Biochem Pharmacol       Date:  1984-02-01       Impact factor: 5.858

7.  Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya.

Authors:  W M Watkins; D G Sixsmith; H C Spencer; D A Boriga; D M Kariuki; T Kipingor; D K Koech
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

8.  Acetaminophen toxicity in human lymphocytes in vitro.

Authors:  S P Spielberg
Journal:  J Pharmacol Exp Ther       Date:  1980-05       Impact factor: 4.030

Review 9.  Drug-induced agranulocytosis.

Authors:  G A Young; P C Vincent
Journal:  Clin Haematol       Date:  1980-10

10.  Amodiaquine as a prodrug: importance of metabolite(s) in the antimalarial effect of amodiaquine in humans.

Authors:  F C Churchill; L C Patchen; C C Campbell; I K Schwartz; P Nguyen-Dinh; C M Dickinson
Journal:  Life Sci       Date:  1985-01-07       Impact factor: 5.037

View more
  5 in total

Review 1.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 2.  Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa.

Authors:  Fatai A Fehintola; Olusegun O Akinyinka; Isaac F Adewole; Chiedza C Maponga; Qing Ma; Gene D Morse
Journal:  Curr Drug Metab       Date:  2011-01       Impact factor: 3.731

Review 3.  [Evaluation of hematologic side effects of anti-infective therapy: agranulocytosis caused by beta-lactam antibiotics, vancomycin and amodiaquine].

Authors:  G Eich; K A Neftel
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia.

Authors:  Lyda Osorio; Iveth Gonzalez; Piero Olliaro; Walter R J Taylor
Journal:  Malar J       Date:  2007-02-28       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.